Accent Microcell Limited (NSE:ACCENTMIC)
609.05
+6.35 (1.05%)
Nov 11, 2026, 12:13 PM IST
Accent Microcell Revenue
Accent Microcell had revenue of 1.75B INR in the half year ending September 30, 2026, with 38.59% growth. This brings the company's total for the last twelve months to 3.85B, up 38.45% year-over-year. In the fiscal year ending March 31, 2026, Accent Microcell had annual revenue of 3.50B with 32.03% growth. That makes Accent Microcell the 29,351st largest company in the world by revenue and 2,015th in India.
Revenue (ttm)
3.85B
Revenue Growth
+38.45%
P/S Ratio
3.79
Revenue / Employee
14.81M
Employees
260
Market Cap
14.61B
Revenue by Segment
Fiscal year ended Mar 31, 2026 See the full Accent Microcell breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 3.50B | 848.35M | 32.03% |
| Mar 31, 2025 | 2.65B | 192.53M | 7.84% |
| Mar 31, 2024 | 2.46B | 483.37M | 24.50% |
| Mar 31, 2023 | 1.97B | 315.51M | 19.04% |
| Mar 31, 2022 | 1.66B | 322.98M | 24.21% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Remus Pharmaceuticals | 10.69B |
| Infinium Pharmachem | 1.90B |
| Zenith Drugs | 1.71B |
| Quest Laboratories | 1.12B |
| Sotac Pharmaceuticals | 1.01B |
| Sunrest Lifescience | 708.33M |
| Vilin Bio Med | 422.63M |
| Medicamen Organics | 226.83M |